3 Vaccines in Pre-clinical Stages
6 Vaccines in Clinical Trials
Multiple vaccine candidates in different stages of development, some may get licensed in the next few weeks.
The vaccine may require 2-3 doses, 3 to 4 weeks apart.
(Chimpanzee Adenovirus)
Indian Manufacturer- Serum Institute of India, Pune
Collaborator- Astra Zeneca
Current Stage- Phase II/III, Applied for EUA (Emergency Use Authorization)
(Inactivated Virus)
Indian Manufacturer- Bharat Biotech International Ltd, Hyderabad
Collaborator- Indian Council of Medical Research, India
Current Stage- Phase III, Applied for EUA (Emergency Use Authorization)
(DNA vaccine)
Indian Manufacturer- Cadila Healthcare Ltd, Ahemdabad
Collaborator- Department of Biotechnology, India
Current Stage- Phase II
(Human Adenovirus vaccine)
Indian Manufacturer- Dr. Reddy's Laboratory, Hyderabad
Collaborator- Gamaleya National Center, Russia
Current Stage- Phase-II over, Phase-III to start next week
(Protein Sub-unit)
Indian Manufacturer- Serum Institute of India, Pune
Collaborator- Novawax
Current Stage- Phase III under consideration
(Protein Antigen based vaccine)
Indian Manufacturer- Biological E Ltd, Hyderabad
Collaborator- MIT, USA
Current Stage- Pre-clinical animal studies concluded, Phase-I+II human clinical trials started
(mRNA based vaccine)
Indian Manufacturer- Genova, Pune
Collaborator- HDT, USA
Current Stage- Pre-clinical animal studies over, Clinical trials (Phase-I and II to start)
(rabies vector platform)
Indian Manufacturer- Bharat Biotech International Ltd, Hyderabad
Collaborator- Thomas Jefferson University
Current Stage- Pre-clinical (Advanced)
NEGVAC (National Expert Group on Vaccine Administration for COVID-19) is working on management f vaccine roll-out and have suggested the following priority groups-
Healthcare Workers (HCWS)
About 1 crore healthcare providers both government and private
Frontline Workers (FLWS)
About 2 crore personnel from State & Central Police department, Armed forces, Home guards & Civil Defense Organization
Prioritized Age Group
About 27 crore people above the age of 50 years & persons with associated comorbidities.
Even after vaccination, COVID-19 precautions must be undertaken.
0 Comments